It's Your August logoGet Started

Research and data

The published numbers, in plain language.

We collect results from peer-reviewed studies and put them next to an explanation of what they actually mean. Every figure links to the original paper or organization, so you can read it for yourself. This is general information, not medical advice, and it does not predict what will happen in your body.

GLP-1 medicines

Semaglutide and tirzepatide are the two most studied medicines in this class. These trials used brand-name products at set doses; individual results vary, and your provider decides whether a medicine like this fits your situation.

Semaglutide

STEP 1

New England Journal of Medicine, 2021

14.9%

average body weight lost over 68 weeks, versus 2.4% on placebo

86.4%

of participants lost at least 5% of their body weight

15.3 kg

average weight lost, versus 2.6 kg on placebo

1,961 adults with overweight or obesity, without diabetes. Trial used a 2.4 mg weekly dose of a brand-name product.

Read the study

Tirzepatide

SURMOUNT-1

New England Journal of Medicine, 2022

20.9%

average body weight lost at the highest dose over 72 weeks

15.0%

average body weight lost at the lowest dose, versus 3.1% on placebo

57%

of participants on the highest dose lost 20% or more of their body weight

2,539 adults with obesity or overweight plus a weight-related condition, without diabetes. Trial used brand-name doses of 5, 10 and 15 mg weekly.

Read the study

Cagrilintide plus semaglutide

REDEFINE 1 (CagriSema)

New England Journal of Medicine, 2025

20.4%

average body weight lost over 68 weeks, versus 3.0% on placebo

17.3 points

estimated difference against placebo, on the main analysis

3,417

adults randomly assigned in the trial

Adults with obesity, or overweight with at least one weight-related condition, without diabetes. CagriSema combines cagrilintide, an amylin analogue, with semaglutide. It is still under FDA review and August does not offer it.

Read the study

The CagriSema programme is still being reviewed. The manufacturer reported up to 22.7% body weight lost in adults without diabetes and 15.7% in adults with type 2 diabetes, and filed its US application in December 2025, according to the American Diabetes Association and Novo Nordisk. Nothing here means a medicine is right for you.

Testosterone

Testosterone matters for drive, energy and mood, and levels drift down with age. The useful part of the research is how reliably low levels can be spotted, which turns out to be by blood test rather than by symptoms alone.

How common

Endocrine Society patient library

About 35%

of men older than 45 are estimated to have hypogonadism

1% a year

typical decline in testosterone after age 30

The same source notes higher rates in men with obesity or type 2 diabetes.

Read the study

Systematic review

Symptoms alone do not confirm low testosterone

40 studies

compared symptoms with measured testosterone in aging men

Weak signal

the strongest single symptom only modestly raised the chance of a low level

This is why diagnosis needs blood tests, not a checklist of how you feel.

Read the study

A diagnosis of low testosterone usually needs two early morning blood tests alongside symptoms, according to the Endocrine Society.

Low hormones in women: the right words

People ask what to call it when estrogen, testosterone or progesterone runs low. These are the terms clinicians actually use, including the two where the medical world has not agreed on a definition yet.

Low testosterone in women

Androgen deficiency, also called androgen insufficiency.

The name exists, but the syndrome does not. The Endocrine Society advises against diagnosing an androgen deficiency syndrome in healthy women, because no well-defined set of signs has been agreed and measured levels do not track symptoms. The one evidence-based use of testosterone in women is low sexual desire after menopause.

Endocrine Society clinical practice guideline, Androgen Therapy in Women

Low progesterone

No agreed deficiency syndrome.

Progesterone is studied mostly through its breakdown product allopregnanolone, which acts on GABA receptors and has a calming effect. Both fall across the menopause transition, and some women notice more anxiety and poorer sleep in that window. There is no accepted blood level that defines a progesterone deficiency.

Editorial, Menopause and Mental Health, Journal of Midlife Health, 2025

A note on testing: the same hormone can read differently at different times of day and different points in a cycle, which is why lab panels are usually repeated before anyone calls a level low.

Weight change, estrogen, and mood

After menopause, fat tissue becomes one of the body's main sources of estrogen: an enzyme in fat called aromatase converts androgens into estrone and estradiol. When fat comes off, part of that supply goes with it, and the studies below show estrogen levels moving down alongside BMI.

Cohort study

Estradiol falls as BMI falls

Journal of Clinical Endocrinology & Metabolism, 2013

12.7%

lower estradiol for each 1 kg/m² of BMI lost, in women whose BMI came down

10.7%

lower testosterone for the same size of BMI change

177 postmenopausal women from a UK cohort, with blood samples taken about six years apart. The same pattern did not hold as strongly when BMI rose.

Read the study

Randomized trial

Estrone fell with diet, and with exercise

Journal of Clinical Oncology, 2012

9.6%

less estrone on a reduced-calorie diet, compared with the control group

11.1%

less estrone when diet was combined with exercise

439 overweight or obese postmenopausal women followed for 12 months. Exercise alone lowered estrone 5.5%.

Read the study

Where mood fits in: new depressive symptoms cluster in the phase of the menopause transition marked by estradiol withdrawal, and experimentally lowering estradiol brings mood symptoms in some women who are vulnerable to them, as summarized by the National Institute of Mental Health review of sex hormones and mood. Short-term estradiol has also lifted mood in depressed perimenopausal women in randomized trials.

No study has yet shown that an estrogen drop caused by weight change, on its own, causes depression. So treat this as a reasonable possibility worth checking rather than a conclusion. If mood slides after a significant amount of weight comes off, the useful next step is a provider review that looks at both sides of it: how much you are actually eating, sleep, protein, iron and thyroid, and your hormone levels.

Feeling flat: serotonin, dopamine and carbs

Two neurotransmitters come up in this conversation and they do different jobs. Serotonin is mostly about feeling steady and content. Dopamine is about reward, motivation and the pull toward doing things. Estrogen supports both: it raises serotonin availability in the brain and interacts with dopamine signalling, as described in a review of mood disorders and hormonal status across a woman's life.

Carbohydrates matter here for one specific reason. A carbohydrate-rich meal raises the ratio of tryptophan, the raw material for serotonin, against the other amino acids that compete with it for entry into the brain, while a protein-heavy meal lowers that ratio. How much that chemistry shifts a person's day-to-day mood is still not settled.

Randomized trial

Oral semaglutide and working for rewards

JAMA Psychiatry, 2026

72

adults with depression and a BMI of 25 or higher, randomized for 16 weeks

More willing

participants on semaglutide showed a pattern of greater willingness to exert physical effort for rewards

A small trial of oral semaglutide added to usual care. It measured effort-based decision making, not mood diagnoses, and the drug was not being tested as a depression treatment.

Read the study

Human meal study

Carbohydrate, protein, and the serotonin precursor

American Journal of Clinical Nutrition, 2003

Higher ratio

after a carbohydrate-rich breakfast, tryptophan rose against the amino acids that compete with it for entry to the brain

Lower ratio

after a protein-rich breakfast, the same ratio fell

Tryptophan is the raw material for serotonin. A companion study in healthy adults found the ratio rose about 20% after starch and 34% after sucrose, and fell 45% after a fat and protein meal.

Read the study

GLP-1 medicines also touch reward signalling. In animals, semaglutide blunts the dopamine response to highly palatable food, described in a study in Science, which is part of why food stops pulling so hard. Whether that flattens mood in people is still open. Regulatory reviews in the United States and the United Kingdom have not found evidence that these medicines cause suicidal thoughts: the FDA has since asked for that warning to be removed from three approved weight management labels, and the UK's MHRA reached the same conclusion.

So if you feel flat on a GLP-1, several things can be behind it, and they are separable:

  • Eating much less than the body needs, or too little protein for the hours you are awake
  • Sleep that has got shorter or shallower
  • Low iron, thyroid problems, or low vitamin D
  • Hormone shifts: perimenopause, low estrogen, or low testosterone
  • The medicine's own effect on reward signalling, which some people notice and others do not

What sorts them out is a blood panel plus a provider review, not guessing. Start with lab panels, and read the nutrition and hydration guide while you are here.

What we will add next

We only publish a number once we have read the source behind it. These topics are queued for the same treatment.

  • Sleep apnea
  • Inflammation
  • Autoimmune conditions
  • Breast cancer risk
  • Thyroid and iron

All medical care on this site is overseen by Elite Care Health. Read the men's health guide.